• PET/CT Technologist

    Job Locations US-FL-Aventura
    Type PRN (Per Diem)
    Updated Date
    2999 NE 191st Street
    As Needed
  • Overview

    PET/CT Technologist


    Akumin is changing the perception of diagnostic testing. Committed to providing excellence in diagnostic imaging, Akumin is on a mission to be the preferred provider.  Our facility is currently looking for an experienced PET/CT Technologist to join our team.


    Akumin provides competitive salaries with bonus program.


    PET/CT Technologist

    • Perform diagnostic PET/CT and computed tomography examinations to ensure the quality and continuity of patient care to include: injection of radiopharmaceutical and/or IV contrast, the administration of oral contrast, protocol setup, patient positioning, reconstruction and network image transfers
    • Understands the contraindications associated with the administration of IV contrast, be able to recognize possible reactions and know the procedure to follow in case of a reaction
    • Provides protection for patient and self in accordance with radiation safety standards
    • Assist with the workflow of the department to ensure the completion of work assignments
    • Demonstrate knowledge, understanding, and competency in clinical area of the practice
    • Demonstrate the ability to use all channels of communication to address inter- and intradepartmental concerns, solve problems, and address conflict
    • Other duties as assigned


    PET/CT Technologist


    Qualified candidates will have:

    • PET/CT and Nuclear Medicine experience is required
    • CNMT or ARRT (N) is required, ARRT (CT) is required
    • State license is required
    • CPR certification is required
    • IV Skills required


    • Completion of an accredited Nuclear Medicine program with at least 1 year of PET/CT and Diagnostic experience


    Other Skills and Abilities

    • Familiarity with current software packages such as Microsoft Word, Excel and Outlook. 


    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed